Jiu'an Medical: Announcement on the resignation of independent directors and the by-election of independent directors

Securities code: 002432 Securities abbreviation: Jiuan Medical Announcement number: 2026-056 Tianjin Jiuan Medical Electronics Co., Ltd.

Announcement on the resignation of independent directors and the by-election of independent directors

The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete, and there are no false records, misleading statements or major omissions.

1. Resignation of independent directors

The company's board of directors recently received the resignation report from Ms. Zhang Lin, the company's independent director. Due to personal work arrangements, Ms. Zhang Lin applied to resign as the company's independent director, member of the Audit Committee, member of the Strategy Committee, and chairman of the nomination committee. After this resignation, Ms. Zhang Lin no longer holds any position in the company.

According to the provisions of the "Measures for the Management of Independent Directors of Listed Companies", "Shenzhen Stock Exchange Self-Regulatory Guidelines for Listed Companies No. 1 - Standardized Operation of Main Board Listed Companies" and the Articles of Association, Ms. Zhang Lin will continue to perform her duties as an independent director and in various special committees until the company's shareholders' meeting elects a new independent director. Ms. Zhang Lin's resignation report will take effect after the company's shareholders' meeting elects a new independent director. As of the disclosure date of this announcement, Ms. Zhang Lin does not hold any shares of the company and has no unfulfilled public commitments.

Ms. Zhang Lin performed her duties diligently and diligently during her tenure as an independent director of the company, and played an active and important role in the company's standardized governance and development. The company's board of directors expresses its heartfelt thanks to her for her contribution to the company's development during her tenure!

2. Election of independent directors

In order to ensure the standardized operation of the board of directors and meet the needs of corporate governance, in accordance with the provisions of the "Company Law", "Shenzhen Stock Exchange Self-Regulatory Guidelines for Listed Companies No. 1 - Standardized Operation of Main Board Listed Companies" and the "Articles of Association", the company held the eighth meeting of the seventh board of directors on August 24, 2026, and reviewed and approved the "Proposal on the Supplementary Election of Independent Directors of the Seventh Board of Directors of the Company". The details are as follows:

With my consent, the company's nomination, and the qualification review of the company's board of directors' nomination committee, the company held the eighth meeting of the seventh board of directors on August 24, 2026, and reviewed and approved the "Proposal on the By-election of Independent Directors of the Company's Seventh Board of Directors" and agreed to nominate Ms. Zhai Shuping as an independent director candidate for the company's seventh board of directors (see the attachment for resume details). After being elected as an independent director of the company by the company's shareholders' meeting, Ms. Zhai Shuping took over the positions of member of the strategy committee, audit committee, and chairman of the nomination committee of the board of directors. Her term starts from the date of review and approval by the company's shareholders' meeting and ends on the expiration date of the seventh session of the board of directors. Upon expiration of the term, he may be re-elected, but his consecutive term shall not exceed six years.

Ms. Zhai Shuping has obtained the independent director qualification certificate recognized by the China Securities Regulatory Commission. Regarding the nomination of independent director candidates, the Nomination Committee of the seventh board of directors of the company issued a review opinion and concluded that the candidates meet the requirements for independent director qualifications. The proposal still needs to be submitted to the company's shareholders' meeting for review. Among them, the qualifications and independence of independent director candidates must be filed and reviewed by the Shenzhen Stock Exchange without objection before they can be submitted to the shareholders' meeting for election. For details of the statement and commitment of the independent director candidate and the statement and commitment of the independent director nominee, please refer to the relevant documents disclosed by the company on the cninfo.com on the same day.

Announcement is hereby made.

Board of Directors of Tianjin Jiuan Medical Electronics Co., Ltd.

August 25, 2026

Attachment: Introduction to Independent Director Candidates

Zhai Shuping, female, Chinese nationality, no permanent residence abroad, born in September 1975, holds a PhD in Economics from Tianjin University of Finance and Economics. From April 2013 to present, he serves as an associate professor, professor and doctoral supervisor at the School of Accountancy of Tianjin University of Finance and Economics, engaged in financial management teaching and scientific research. Since May 2026, he has served as an independent director of Jinyao Darentang Group Co., Ltd. He currently serves as an external director of many state-owned enterprises such as Tianjin Bohai Chemical Group Co., Ltd. and Tianjin Tourism (Holding) Group Co., Ltd.

Ms. Zhai Shuping does not directly or indirectly hold shares in the company, and has no relationship with shareholders, actual controllers, other directors, and senior managers who hold more than 5% of the company's shares. She has not been punished by the China Securities Regulatory Commission and other relevant departments or disciplinary sanctions from stock exchanges, and has not been punished by judicial authorities for suspected crimes. A case has been filed for investigation or a case has been filed for investigation by the China Securities Regulatory Commission for suspected violations of laws and regulations, but no clear conclusion has been reached; it is not a person subject to enforcement for breach of trust; it meets the relevant director's office requirements stipulated in the "Company Law", "Shenzhen Stock Exchange Self-Regulatory Guidelines No. 1 - Standardized Operation of Main Board Listed Companies" and the "Articles of Association".